Cargando…

mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development

Hepatoblastoma (HB) is the most common pediatric liver malignancy. Around 80% of HB demonstrate simultaneous activation of β-catenin and Yes-associated protein 1 (Yap1). The mechanism by which these signaling pathways contribute to HB pathogenesis remain obscure. Recently, mTORC1 activation was repo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molina, Laura, Yang, Hong, Adebayo Michael, Adeola O., Oertel, Michael, Bell, Aaron, Singh, Sucha, Chen, Xin, Tao, Junyan, Monga, Satdarshan P.S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407673/ https://www.ncbi.nlm.nih.gov/pubmed/30863496 http://dx.doi.org/10.18632/oncotarget.26668

Ejemplares similares

Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development
por: Molina, Laura, et al.
Publicado: (2019)

Hepatocyte‐Specific β‐Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes
por: Russell, Jacquelyn O., et al.
Publicado: (2019)

Loss of TAZ after YAP deletion severely impairs foregut development and worsens cholestatic hepatocellular injury
por: Gabdulkhakova, Adelya, et al.
Publicado: (2023)

Endothelial Wnts regulate β‐catenin signaling in murine liver zonation and regeneration: A sequel to the Wnt–Wnt situation
por: Preziosi, Morgan, et al.
Publicado: (2018)

β-Catenin Loss in Hepatocytes Promotes Hepatocellular Cancer after Diethylnitrosamine and Phenobarbital Administration to Mice
por: Awuah, Prince Kwaku, et al.
Publicado: (2012)

β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction
por: Hu, Shikai, et al.
Publicado: (2021)

β-Catenin Activation in Hepatocellular Cancer: Implications in Biology and Therapy
por: Krutsenko, Yekaterina, et al.
Publicado: (2021)

HGF/c-Met related activation of β-catenin in hepatoblastoma
por: Purcell, Rachel, et al.
Publicado: (2011)

Compensatory hepatic adaptation accompanies permanent absence of intrahepatic biliary network due to YAP1 loss in liver progenitors
por: Molina, Laura M., et al.
Publicado: (2021)

Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice
por: Qiao, Yu, et al.
Publicado: (2018)

Beta-catenin is required for Ron receptor induced mammary tumorigenesis
por: Wagh, Purnima K., et al.
Publicado: (2011)

YAP enters the mTOR pathway to promote tuberous sclerosis complex
por: Liang, Ning, et al.
Publicado: (2015)

Interaction of YAP1 and mTOR promotes bladder cancer progression
por: Xu, Mingxi, et al.
Publicado: (2019)

Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma
por: Sha, Ying-Li, et al.
Publicado: (2019)

YAP accelerates vascular senescence via blocking autophagic flux and activating mTOR
por: Pan, Xianmei, et al.
Publicado: (2020)

Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development
por: Liu, Pin, et al.
Publicado: (2017)

Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex
por: Liang, Ning, et al.
Publicado: (2014)

YAP manipulates proliferation via PTEN/AKT/mTOR-mediated autophagy in lung adenocarcinomas
por: Xu, Wei, et al.
Publicado: (2021)

Activation of WNT/Beta‐Catenin Signaling and Regulation of the Farnesoid X Receptor/Beta‐Catenin Complex After Murine Bile Duct Ligation
por: Zhang, Rong, et al.
Publicado: (2019)

MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β‐catenin and Wnt signaling
por: Indersie, Emilie, et al.
Publicado: (2017)

Increased Expression of YAP Inhibited the Autophagy Level by Upregulating mTOR Signal in the Eutopic ESCs of Endometriosis
por: Pei, Tianjiao, et al.
Publicado: (2022)

Lactobacilli Differentially Modulate mTOR and Wnt/ β-Catenin Pathways in Different Cancer Cell Lines
por: Taherian-Esfahani, Zahra, et al.
Publicado: (2016)

New insights into the pathophysiology of the tuberous sclerosis complex: Crosstalk of mTOR- and hippo-YAP pathways in cell growth
por: Dill, Patricia E, et al.
Publicado: (2015)

Silibinin Induced Human Glioblastoma Cell Apoptosis Concomitant with Autophagy through Simultaneous Inhibition of mTOR and YAP
por: Bai, Zhuan-Li, et al.
Publicado: (2018)

The Emerging Roles of Cancer Stem Cells and Wnt/Beta-Catenin Signaling in Hepatoblastoma
por: Mavila, Nirmala, et al.
Publicado: (2019)

Modeling hepatoblastoma development with human fetal liver organoids reveals YAP1 activation is sufficient for tumorigenesis
por: Yang, Li, et al.
Publicado: (2021)

Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
por: Arend, Rebecca C., et al.
Publicado: (2016)

Plasticity and mTOR: Towards Restoration of Impaired Synaptic Plasticity in mTOR-Related Neurogenetic Disorders
por: Gipson, Tanjala T., et al.
Publicado: (2012)

Dietary protein sources differentially affect microbiota, mTOR activity and transcription of mTOR signaling pathways in the small intestine
por: Kar, Soumya K., et al.
Publicado: (2017)

Conditional cell reprogramming involves non-canonical β-catenin activation and mTOR-mediated inactivation of Akt
por: Suprynowicz, Frank A., et al.
Publicado: (2017)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Where is mTOR and what is it doing there?
por: Betz, Charles, et al.
Publicado: (2013)

Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1
por: Gest, Caroline, et al.
Publicado: (2023)

Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
por: Arend, Rebecca C., et al.
Publicado: (2018)

Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations
por: Regel, Ivonne, et al.
Publicado: (2020)

Single-cell spatial transcriptomics reveals a dynamic control of metabolic zonation and liver regeneration by endothelial cell Wnt2 and Wnt9b
por: Hu, Shikai, et al.
Publicado: (2022)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

DPEP1 is a direct target of miR-193a-5p and promotes hepatoblastoma progression by PI3K/Akt/mTOR pathway
por: Cui, Xichun, et al.
Publicado: (2019)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

ZO-2 silencing induces renal hypertrophy through a cell cycle mechanism and the activation of YAP and the mTOR pathway
por: Domínguez-Calderón, Alaide, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_agao6buvohm21k4bj2t89l7qr0